Hagop Kantarjian/mdanderson.org
Apr 1, 2025, 15:09
Hagop Kantarjian: Success, optimism, and challenges on the therapeutic horizon of acute myeloid leukemia
Hagop Kantarjian, Professor and Chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, posted on X about recent paper he and his colleagues co-authored:
“Check out our comprehensive review on AML from an MD Anderson Cancer Center perspective, published in ACS Journal Cancer.
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges.”
Authors: Jayastu Senapati, Hagop Kantarjian, et al.
More posts featuring Hagop Kantarjian.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 5, 2025, 19:11
Aug 5, 2025, 18:55
Aug 5, 2025, 18:30
Aug 5, 2025, 18:18
Aug 5, 2025, 18:04
Aug 5, 2025, 17:52